Hypercalcemia in Parathyroid Carcinoma

• FDA approval · 2026-03-23
  FDA Approved: CINACALCET — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for cinacalcet from Aurobindo Pharma Limited, allowing a generic version to be marketed.

• FDA approval · 2020-05-18
  FDA Approved: CINACALCET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for a generic version of cinacalcet from Sun Pharmaceutical Industries, enabling marketing of th…

• FDA approval · 2018-03-08
  FDA Approved: CINACALCET — Original Application (Aurobindo Pharma Limited)

  FDA approves Aurobindo Pharma Limited's original application for cinacalcet (generic) to treat secondary hyperparathyroidism in adults with …